taking semaglutide and tirzepatide vs. Semaglutide: Understanding Your Weight Loss Medication Options Switching Semaglutide to Tirzepatide |

Nat Immunol (2010) 11:37384

Used medication as tool to establish sustainable routines, not just relied on appetite suppression Rapid response to regain

In Phase 2 trials (the TRIUMPH-2 study involving 338 participants over 48 weeks), the 12 mg dose of Retatrutide produced an average weight loss of 24.2%

Adverse reactions that occurred in at least 5% of patients and were numerically more frequent during the dose-escalation phase of lamotrigine tablets in these trials (when patients may have been receiving concomitant medications) compared with the monotherapy phase were: headache (25%), rash (11%), dizziness (10%), diarrhea (8%), dream abnormality (6%), and pruritus (6%)